A01-Request for Information PANDHA-25-P-0000 003354.pdf
PDF 112 KB Posted
- Solicitation number
- PANDHA-25-P-0000_003354
- Issued by
-
Defense Health Agency
About this file
This Request for Information (RFI) seeks to determine the availability of commercial items for DNA Aptamer-based Therapeutic Development. The RFI is issued by the Defense Health Agency to explore potential capabilities for a two-year study focused on developing conjugated aptamers as antimicrobial agents. Interested parties are invited to submit electronic responses via Microsoft Word or Adobe PDF by 10:00 AM ET on 1 April 2025 to Ms. Linda Hinson at linda.t.hinson.civ@health.mil.
Respondents must provide a 3-page capabilities statement following specific formatting guidelines, including a cover page with organizational details, technical points of contact, topic areas, and NAICS code. The RFI emphasizes that this is an information-gathering exercise only, does not constitute a solicitation, and responses will not form a binding contract. All submitted information will be treated as confidential business information, with responders responsible for their own submission expenses.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Request for Information (RFI) Deoxyribonucleic Acid (DNA) Aptamer-based Therapeutic Development
General Information:
This is an RFI as defined in FAR 15.201(e) to ascertain whether a commercial item exists that provides the capabilities described herein.
This RFI is issued solely for information and planning purposes and does not constitute a solicitation. All information received in response to this RFI will be treated as business confidential information.
Nonetheless, submitters should properly mark their responses if the information is confidential.
Responses to the RFI will not be returned. Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expense associated with responding to this RFI.
RFI Response and due date: 1 April 2025
Instructions to Responders:
Responses from all capable and qualified sources are encouraged to respond to this request.
White papers should adhere to the following formatting and outline instructions:
1. All submissions shall be made electronically and be in one of the following formats: Microsoft Word or Adobe PDF.
2. Cover Page (1page)
• Title
• Organization
• Responders technical and administrative points of contact (names, addresses, phone, fax number and email addresses)
• Topic area(s) addressed
• NAICS Code
3. Interested parties are asked to respond to this RFI and submit a capabilities statement that supports the focus of this RFI as detailed below. Please review the place of performance requirements. Please submit written responses via email in Microsoft Office 2000 or 2007 format or Adobe PDF. All responses should be complete: in 12-point font; and not to exceed 3 pages total, including graphics, tables, and appendices.
No hardcopies shall be accepted. No written solicitation document is available at this time. Telephone requests will not be honored, and no bidders list shall be maintained. No inquiries regarding any potential future acquisition activities shall be entertained.
Potential offerors are requested to direct all questions via email to the Point of Contact listed below.
Responses are due to the Point of Contact, Ms. Linda Hinson at email: linda.t.hinson.civ@health.mil no later than 10:00AM ET, 1 April 2025.
mailto:linda.t.hinson.civ@health.mil
Request for Information (RFI)
File details come from the government source that posted it. Updated .